Patents Assigned to Al Therapeutics, Inc.
  • Inhalable rapamycin formulation for treating age-related conditions
    Patent number: 11648199
    Abstract: The present invention relates to methods and compositions for anti-aging therapy and for the treatment and prophylaxis of age-related diseases and disorders in a human subject in need of such therapy or treatment, the methods comprising the pulmonary administration to the subject, preferably via inhalation, of composition comprising rapamycin, or a prodrug or derivative thereof.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: May 16, 2023
    Assignee: Al Therapeutics, Inc.
    Inventors: Thomas Armer, Lawrence S. Melvin, Jr., Jonathan M. Rothberg, Henri Lichenstein